Victory Capital Management
CSBR icon

Victory Capital Management’s Champions Oncology CSBR Stock Holding History

Victory Capital Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,054
Closed -$16K – 2687
2020
Q1 		$16K Buy
+2,054
New +$14.4K ﹤0.01% 3160
2019
Q4 		– Sell
-1,150
Closed -$6K – 2782
2019
Q3 		$6K Buy
+1,150
New +$7.46K ﹤0.01% 3405

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OMC
Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return

Victory Capital Management's CSBR Position: Q2 2020 in Review

Victory Capital Management sold out of Champions Oncology (CSBR) in Q2 2020, closing a stake of 2,054 shares — an estimated $16K sold.

Victory Capital Management first reported a position in CSBR in Q3 2019 and held it in 2 quarters. The position peaked at $16K in Q1 2020. 44 funds tracked by Wall St. Rank hold CSBR as of Q2 2020.

  • Victory Capital Management reported no remaining Champions Oncology position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 2,054 Champions Oncology shares in Q2 2020, an estimated $16K.
  • Victory Capital Management first reported a position in Champions Oncology in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Champions Oncology position peaked at $16K in Q1 2020.
  • 44 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.